LRP-1-mediated intracellular antibody delivery to the Central Nervous System
Citations Over TimeTop 10% of 2015 papers
Abstract
The blood-brain barrier (BBB) is by far the most important target in developing new approaches to improve delivery of drugs and diagnostic tools into the Central Nervous System (CNS). Here we report the engineering of pH- sensitive polymersomes (synthetic vesicles formed by amphiphilic copolymers) that exploit endogenous transport mechanisms to traverse the BBB, enabling delivery of large macromolecules into both the CNS parenchyma and CNS cells. We achieve this by targeting the Low Density Lipoprotein Receptor-Related Protein 1 (LRP-1) receptor. We show that LRP-1 is associated with endothelial transcytosis that does not involve acidification of cargo in membrane-trafficking organelles. By contrast, this receptor is also associated with traditional endocytosis in CNS cells, thus aiding the delivery of relevant cargo within their cytosol. We prove this using IgG as a model cargo, thus demonstrating that the combination of appropriate targeting combined with pH-sensitive polymersomes enables the efficient delivery of macromolecules into CNS cells.
Related Papers
- → LRP1 mediates bidirectional transcytosis of amyloid-β across the blood-brain barrier(2010)127 cited
- → Visualization of the binding, endocytosis, and transcytosis of low-density lipoprotein in the arterial endothelium in situ.(1983)355 cited
- → Transcytosis and Traffic of Membranes in the Endothelial Cell(1981)40 cited
- Screening Functionalised Polymersomes Targeting Transcytosis Across Blood-Brain Barrier(2014)
- LRP-1-mediated blood brain barrier transcytosis: mechanisms and therapeutic applications(2016)